Attached files
file | filename |
---|---|
8-K - 8-K - MERIT MEDICAL SYSTEMS INC | a11-14744_48k.htm |
EX-5.1 - EX-5.1 - MERIT MEDICAL SYSTEMS INC | a11-14744_4ex5d1.htm |
EX-1.1 - EX-1.1 - MERIT MEDICAL SYSTEMS INC | a11-14744_4ex1d1.htm |
EX-99.2 - EX-99.2 - MERIT MEDICAL SYSTEMS INC | a11-14744_4ex99d2.htm |
Exhibit 99.1
1600 West Merit Parkway · South Jordan, UT 84095
Telephone: 801-253-1600 · Fax: 801-253-1688
PRESSRELEASE
FOR IMMEDIATE RELEASE
Date: |
June 16, 2011 |
Contact: |
Anne-Marie Wright, Vice President, Corporate Communications |
Phone: |
(801) 208-4167 e-mail: awright@merit.com Fax: (801) 253-1688 |
MERIT MEDICAL SYSTEMS, INC. ANNOUNCES
COMMENCEMENT OF PUBLIC OFFERING OF COMMON STOCK
SOUTH JORDAN, UTAH Merit Medical Systems, Inc. (NASDAQ: MMSI) a leader in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures, today announced that it intends to offer shares of its common stock in a public offering. Piper Jaffray & Co. is acting as the sole manager for the offering.
Merit expects to use the net proceeds from the offering to partially repay debt under its existing credit facility, to expand manufacturing facilities, for potential strategic acquisitions, and general corporate purposes.
This offering, if commenced, will be made pursuant to a prospectus supplement to Merits prospectus, dated December 30, 2010, filed as part of Merits effective $150 million shelf registration statement. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities nor will there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
Copies of the preliminary prospectus supplement and accompanying prospectus relating to these securities may be obtained by contacting Piper Jaffray & Co., by mail at 800 Nicollet Mall, Suite 800, Minneapolis, MN 55402, or by telephone at (800) 747-3924.
ABOUT MERIT
Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force totaling approximately 130 individuals. Merit employs approximately 2,200 people worldwide with facilities in Salt Lake City and South Jordan, Utah; Angleton, Texas; Richmond, Virginia; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Copenhagen, Denmark; and Rockland, Massachusetts.
Statements contained in this release which are not purely historical, including, without limitation, statements regarding Merits prospective offering of common stock, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are subject to risks and uncertainties such as those described in Merits Annual Report on Form 10-K for the year ended December 31, 2010. Such risks and uncertainties include risks relating to product recalls and product liability claims; potential restrictions on Merits liquidity or its ability to operate its business by its current debt agreements; possible infringement of Merits technology or the assertion that Merits technology infringes the rights of other parties; the potential of fines, penalties, or other adverse consequences if Merits employees or agents violate the U.S. Foreign Corrupt Practices Act or other laws and regulations; the failure of Merits distributors to effectively distribute Merits products; Merits failure to obtain or maintain regulatory approvals; unapproved or off-label use of Merits products; expenditures relating to research, development, testing and regulatory approval or clearance of Merits products and the risk that such products may not be developed successfully or approved for commercial use; greater governmental scrutiny and regulation of the medical device industry; reforms to the 510(k) process administered by the U.S. Food and Drug Administration; laws targeting fraud and abuse in the healthcare industry; potential for significant adverse changes in, or failure to comply with, governing regulations; increases in the price of commodity components; negative changes in economic and industry conditions in the United States and other countries; termination or interruption of relationships with Merits suppliers, or failure of such suppliers to perform; Merits potential inability to successfully manage growth through acquisitions, including the inability to commercialize technology acquired through recent, proposed or future acquisitions, including the Biosphere acquisition; fluctuations in Euro and GBP exchange rates; Merits need to generate sufficient cash flow to fund its debt obligations, capital expenditures, and ongoing operations; concentration of Merits revenues among a few products and procedures; development of new products and technology that could render Merits existing products obsolete; market acceptance of new products; volatility in the market price of Merits common stock; modification or limitation of governmental or private insurance reimbursement policies; changes in health care markets related to health care reform initiatives; failure to comply with applicable environmental laws; changes in key personnel; work stoppage or transportation risks; uncertainties associated with potential healthcare policy changes which may have a material adverse effect on Merit; introduction of products in a timely fashion; price and product competition; availability of labor and materials; cost increases; fluctuations in and obsolescence of inventory; and other factors referred to in Merits Annual Report on Form 10-K for the year ended December 31, 2010 and other materials filed with the Securities and Exchange Commission. All subsequent forward-looking statements attributable to Merit or persons acting on its behalf are expressly qualified in their entirety by these cautionary statements. Actual results will differ, and may differ materially, from anticipated results. Financial estimates are subject to change and are not intended to be relied upon as predictions of future operating results, and Merit assumes no obligation to update or disclose revisions to those estimates.
# # #